President-elect Donald Trump confirmed that it is "highly unlikely" his administration will revoke access to abortion pills.

Readers question Robert F. Kennedy Jr. and advocate research on HIV prevention and microplastics.

Robert F. Kennedy Jr., Donald Trump’s pick to lead the US Department of Health and Human Services, has been vocally anti-pharma. Pharma, Congress, and the courts, though, all get a say.

The Montana Supreme Court on Wednesday upheld a lower court’s decision blocking a state ban on child sex-change treatments. Sex change treatments ...

Three-quarters of pharma and life sciences executives said they were optimistic for 2025, even though they expect some level ...

A federal jury this week in Maryland convicted two ex-CEOs of a Washington biotech company for their role in a multi-million ...

On September 27, 2024, the U.S. Court of Appeals for the Ninth Circuit reversed the district court’s decision in U.S. v. California Stem ...

A proposed Utah railway would quadruple the Uinta Basin’s oil production if built. Colorado and environmentalists have fought ...

In a February ruling, the Hawaii Supreme Court openly rejected landmark Second Amendment cases that have been decided by the ...

Two cases before the Supreme Court stripped agencies like the FDA, CDC, and NOAA of the leeway to make expert-driven calls on ...

President Donald Trump endorsed it and a year after the FDA approved it, Florida’s plan to import lower-cost drugs from ...

This week, the Environmental Protection Agency moved to largely ban the use of trichloroethylene and tetrachloroethylene, ...